These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27996361)

  • 1. Insight into the molecular mechanism of P-glycoprotein mediated drug toxicity induced by bioflavonoids: an integrated computational approach.
    Wongrattanakamon P; Lee VS; Nimmanpipug P; Sirithunyalug B; Chansakaow S; Jiranusornkul S
    Toxicol Mech Methods; 2017 May; 27(4):253-271. PubMed ID: 27996361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A significant mechanism of molecular recognition between bioflavonoids and P-glycoprotein leading to herb-drug interactions.
    Wongrattanakamon P; Nimmanpipug P; Sirithunyalug B; Chansakaow S; Jiranusornkul S
    Toxicol Mech Methods; 2018 Jan; 28(1):1-11. PubMed ID: 28678657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico study of desmosdumotin as an anticancer agent: homology modeling, docking and molecular dynamics simulation approach.
    Gadhe CG; Kothandan G; Cho SJ
    Anticancer Agents Med Chem; 2013 Dec; 13(10):1636-44. PubMed ID: 23796247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the three-dimensional structure of human P-glycoprotein in absence of ATP by computational techniques embodying crosslinking data: insight into the mechanism of ligand migration and binding sites.
    Vandevuer S; Van Bambeke F; Tulkens PM; Prévost M
    Proteins; 2006 May; 63(3):466-78. PubMed ID: 16463278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking and P-glycoprotein inhibitory activity of flavonoids.
    Daddam JR; Dowlathabad MR; Panthangi S; Jasti P
    Interdiscip Sci; 2014 Sep; 6(3):167-75. PubMed ID: 25205494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flexibility of P-glycoprotein for its poly-specific drug binding from molecular dynamics simulations.
    Liu M; Hou T; Feng Z; Li Y
    J Biomol Struct Dyn; 2013; 31(6):612-29. PubMed ID: 22888853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships.
    Bai J; Zhao S; Fan X; Chen Y; Zou X; Hu M; Wang B; Jin J; Wang X; Hu J; Zhang D; Li Y
    Toxicol Appl Pharmacol; 2019 Apr; 369():49-59. PubMed ID: 30790579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate versus inhibitor dynamics of P-glycoprotein.
    Ma J; Biggin PC
    Proteins; 2013 Sep; 81(9):1653-68. PubMed ID: 23670856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the inward- and outward-open homology models and ligand binding of human P-glycoprotein.
    Pajeva IK; Globisch C; Wiese M
    FEBS J; 2009 Dec; 276(23):7016-26. PubMed ID: 19878299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structure-differential binding method for elucidating the interactions between flavonoids and cytochrome-c by ESI-MS and molecular docking.
    Wang X; Liu Y; Wang H
    Talanta; 2013 Nov; 116():368-75. PubMed ID: 24148417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses.
    Kadioglu O; Saeed ME; Valoti M; Frosini M; Sgaragli G; Efferth T
    Biochem Pharmacol; 2016 Mar; 104():42-51. PubMed ID: 26807479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of modulators to mouse and human multidrug resistance P-glycoprotein. A computational study.
    Jara GE; Vera DM; Pierini AB
    J Mol Graph Model; 2013 Nov; 46():10-21. PubMed ID: 24095875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico modelling of the interaction of flavonoids with human P-glycoprotein nucleotide-binding domain.
    Badhan R; Penny J
    Eur J Med Chem; 2006 Mar; 41(3):285-95. PubMed ID: 16494971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
    Sun B; Song S; Hao CZ; Huang WX; Liu CC; Xie HL; Lin B; Cheng MS; Zhao DM
    J Mol Graph Model; 2015 Mar; 56():10-9. PubMed ID: 25541526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.
    Gadhe CG; Kothandan G; Cho SJ
    J Biomol Struct Dyn; 2013; 31(11):1251-76. PubMed ID: 23153179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance.
    Boumendjel A; Di Pietro A; Dumontet C; Barron D
    Med Res Rev; 2002 Sep; 22(5):512-29. PubMed ID: 12210557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Modeling on Binding Interactions of Cyclodextrin s with the Human Multidrug Resistance P-glycoprotein Toward Efficient Drug-delivery System Applications.
    González-Durruthy M; Concu R; Osmari Vendrame LF; Ortiz Martins M; Zanella I; Ruso JM; Dias Soeiro Cordeiro MN
    Curr Top Med Chem; 2023; 23(1):62-75. PubMed ID: 35240960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1.
    Wesołowska O
    Acta Biochim Pol; 2011; 58(4):433-48. PubMed ID: 22187677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.